Your browser doesn't support javascript.
loading
A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
Changou, Chun A; Shiah, Her-Shyong; Chen, Li-Tzong; Liu, Servina; Luh, Frank; Liu, Shwu-Huey; Cheng, Yung-Chi; Yen, Yun.
Afiliación
  • Changou CA; The PhD program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei, Taiwan.
  • Shiah HS; The PhD program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • Chen LT; The Core Facility Center, Office of Research and Development, Taipei Medical University, Taipei, Taiwan.
  • Liu S; The PhD program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei, Taiwan.
  • Luh F; National Health Research Institutes, Tainan, Taiwan.
  • Liu SH; Sino-American Cancer Foundation, Covina, California, USA.
  • Cheng YC; Sino-American Cancer Foundation, Covina, California, USA.
  • Yen Y; Yiviva Inc., New York, New York, USA.
Oncologist ; 26(3): e367-e373, 2021 03.
Article en En | MEDLINE | ID: mdl-33140457
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article